Indication

Anaplastic astrocytoma

Anaplastic astrocytoma is a malignant, diffusely infiltrating primary brain tumor arising from glial support cells known as astrocytes. Read more about Anaplastic astrocytoma

37 drugs 32 manufacturers

Advertisement

Drugs that treat it

Common Anaplastic astrocytoma therapies.

Showing 19–27 of 37 drugs

TEMOZOLOMIDE

ALKYLATING AGENTS·ANAPLASTIC ASTROCYTOMA·+1
AREVA PHARMACEU

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
STI PHARMA, LLC

TEMOZOLOMIDE

ALKYLATING AGENTS·ANAPLASTIC ASTROCYTOMA·+1
CAMBER PHARMACE

TEMOZOLOMIDE

ALKYLATING AGENTS·ANAPLASTIC ASTROCYTOMA·+1
AVPAK

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
DR.REDDY'S LAB

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ALEMBIC PHARMAC

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ATHENEX PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Anaplastic astrocytoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anaplastic astrocytoma.

Anaplastic astrocytoma is a malignant, diffusely infiltrating primary brain tumor arising from glial support cells known as astrocytes.

Classified historically as a World Health Organization grade III glioma, it most frequently occurs in adults and primarily affects the cerebral hemispheres, though it can arise throughout the central nervous system.

Pathophysiologically, the tumor is characterized by increased cellularity, marked nuclear atypia, and brisk mitotic activity without the prominent microvascular proliferation or necrosis that defines grade IV glioblastoma.

Patients typically present with progressive focal neurological deficits, persistent headaches, cognitive or behavioral changes, and new-onset seizures secondary to localized tissue infiltration and elevated intracranial pressure.

Personalize your experience

Follow Anaplastic astrocytoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it